Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 71 - 80 of 344 reports

U.S. Moebius Syndrome Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: U.S. Moebius Syndrome Market Market Size 2024: USD 186.4 million Market Size 2032: USD 299.5 million CAGR: 6.1% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Botulinum Toxin Dominates Treatment Spend: Botulinum toxin injections … Read More
Published November 2026

U.S. PD L1 Inhibitors Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: PD-L1 Inhibitors Market Size 2024: USD 6.9 billion Market Size 2032: USD 11.4 billion CAGR: 6.5% Base Year: 2025 Forecast Period: 2026-2032 Analyst Findings and Recommendations Finding 01 — Biomarker Labels Route Diagnostic Volume: Atezolizumab's U.S. first-line lung monotherapy … Read More
Published November 2026

U.S. Viral Gastroenteritis Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Viral Gastroenteritis Market Size 2024: USD 2.84 billion Market Size 2032: USD 4.13 billion CAGR: 4.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Diagnostics Capture Near-Term Growth: Reimbursement under CPT 87507, covering 12-to-25-target … Read More
Published November 2026

U.S. Breast Lesion Localization Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Breast Lesion Localization Market Size 2024: USD 412 million Market Size 2032: USD 647 million CAGR: 5.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Radar reflectors displacing wires: Radar reflector localization, led by … Read More
Published November 2026

U.S. Digital Mental Health Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 7.6 billion Market Size 2032: USD 21.5 billion CAGR: 13.9% Market Definition: The U.S. digital mental health market covers telehealth therapy, psychiatric medication management, self-guided apps, and prescription digital therapeutics delivered to patients through commercial, employer, and government payers. … Read More
Published November 2026

U.S. HIV Drugs Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 22.6 billion Market Size 2032: USD 33.4 billion CAGR: 5.0% Market Definition: Branded and generic antiretroviral drugs, including pre-exposure prophylaxis (PrEP) products, sold through U.S. retail, specialty, hospital, and government program channels. Leading Companies: Gilead Sciences, ViiV Healthcare, Merck, … Read More
Published November 2026

U.S. Host Cell Protein Testing Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Host Cell Protein Testing Market Size 2024: USD 412.6 million Market Size 2032: USD 871.4 million CAGR: 9.8% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Mass spectrometry eroding ELISA dominance: Thermo Fisher Scientific … Read More
Published November 2026

U.S. Optical Genome Mapping Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Optical Genome Mapping Market Size 2024: USD 118.6 million Market Size 2032: USD 287.4 million CAGR: 11.7% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Recurring Consumables Drive Economics: Recurring chip and reagent revenue … Read More
Published November 2026

U.S. Pediatric Neurology Devices Market Size, Share & Forecast 2026–2032

Report Highlights Market Size 2024: USD 1.9 billion Market Size 2032: USD 3.1 billion CAGR: 6.4% Market Definition: Pediatric neurology devices are medical systems used to diagnose and treat neurological conditions in patients under 18, including neurostimulators, cerebrospinal fluid shunts, and EEG monitoring systems. The … Read More
Published November 2026

U.S. Concussions Market Size, Share & Forecast 2026–2032

Report Highlights Country: United States Market: Concussions Market Market Size 2024: USD 3.42 billion Market Size 2032: USD 5.88 billion CAGR: 7.0% Base Year: 2025 Forecast Period: 2026-2032 Analyst Findings and Recommendations Finding 01 — Blood Biomarker Reimbursement Gap: Abbott's i-STAT TBI blood test and … Read More
Published November 2026